Yang Michael, Bloomfield Grace C, Case Brian C, Satler Lowell F, Waksman Ron, Ben-Dor Itsik
Division of Cardiovascular Diseases, Scripps Clinic, La Jolla, CA, United States of America.
Georgetown University School of Medicine, Washington, DC, United States of America.
Cardiovasc Revasc Med. 2025 Aug;77:7-11. doi: 10.1016/j.carrev.2024.09.007. Epub 2024 Sep 19.
Anomalous coronary arteries (ACA) are seen in 1-5 % of patients undergoing coronary angiography, and their presence may increase procedural difficulty. We aimed to compare procedural outcomes of coronary angiography in ACA patients by anatomy and prior knowledge of the ACA.
This was a single-center review of ACA patients undergoing coronary angiography between October 2013 and February 2022. Primary endpoints were contrast volume, fluoroscopy dose, time, and dose-area product (DAP). Comparisons were made between groups based on ACA anatomy and based on prior knowledge of the ACA.
We found 176 diagnostic coronary angiograms among ACA patients. Anomalies of the right coronary artery (RCA) comprised 77 %, followed by left circumflex (LCX) at 16 % and left main or left anterior descending (LMCA/LAD) at 7 %. There was significantly more contrast use among patients with RCA (mean 110.5 mL) or LMCA/LAD (115.6 mL) anomalies than LCX (76.2 mL; p = 0.01). There was no difference in fluoroscopy dose, time, or DAP. Prior knowledge of the anomaly was recorded in 61 (35 %) cases. Contrast volume (mean difference 27.1 mL, 95 % confidence interval: 12.5-41.8) and all fluoroscopy measures decreased if the ACA was previously known to the operators.
Different types of ACAs are associated with increased contrast use but not fluoroscopy exposure. Prior knowledge of ACA is associated with decreased contrast use and fluoroscopy exposure. Thorough review of prior catheterizations and knowledge of catheter selection is important for reducing contrast use and fluoroscopy exposure in patients with ACA.
在接受冠状动脉造影的患者中,异常冠状动脉(ACA)的发生率为1% - 5%,其存在可能会增加手术难度。我们旨在根据ACA的解剖结构和对ACA的既往了解情况,比较ACA患者冠状动脉造影的手术结果。
这是一项对2013年10月至2022年2月期间接受冠状动脉造影的ACA患者进行的单中心回顾性研究。主要终点指标为造影剂用量、透视剂量、手术时间和剂量面积乘积(DAP)。根据ACA的解剖结构以及对ACA的既往了解情况对各亚组进行比较。
我们在ACA患者中发现了176例诊断性冠状动脉造影。右冠状动脉(RCA)异常占77%,其次是左旋支(LCX)异常占16%,左主干或左前降支(LMCA/LAD)异常占7%。RCA(平均110.5 mL)或LMCA/LAD(115.6 mL)异常的患者使用的造影剂明显多于LCX异常的患者(76.2 mL;p = 0.01)。透视剂量、手术时间或DAP方面无差异。61例(35%)病例记录了对异常情况的既往了解。如果术者之前已知ACA情况,则造影剂用量(平均差异27.1 mL,95%置信区间:12.5 - 41.8)和所有透视指标均会降低。
不同类型的ACA与造影剂用量增加相关,但与透视暴露无关。对ACA的既往了解与造影剂用量减少和透视暴露减少相关。全面回顾既往导管插入操作并了解导管选择对于减少ACA患者的造影剂用量和透视暴露很重要。